BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 34924382)

  • 1. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.
    Cirrito JR; Deane R; Fagan AM; Spinner ML; Parsadanian M; Finn MB; Jiang H; Prior JL; Sagare A; Bales KR; Paul SM; Zlokovic BV; Piwnica-Worms D; Holtzman DM
    J Clin Invest; 2005 Nov; 115(11):3285-90. PubMed ID: 16239972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.
    Acharya NK; Grossman HC; Clifford PM; Levin EC; Light KR; Choi H; Swanson Ii RL; Kosciuk MC; Venkataraman V; Libon DJ; Matzel LD; Nagele RG
    J Alzheimers Dis; 2024; 98(1):163-186. PubMed ID: 38393907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive decline, Aβ pathology, and blood-brain barrier function in aged 5xFAD mice.
    Nehra G; Promsan S; Yubolphan R; Chumboatong W; Vivithanaporn P; Maloney BJ; Lungkaphin A; Bauer B; Hartz AMS
    Fluids Barriers CNS; 2024 Mar; 21(1):29. PubMed ID: 38532486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-translational modifications of beta-amyloid alter its transport in the blood-brain barrier
    Varshavskaya KB; Petrushanko IY; Mitkevich VA; Barykin EP; Makarov AA
    Front Mol Neurosci; 2024; 17():1362581. PubMed ID: 38516041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of acute rosiglitazone on insulin pharmacokinetics at the blood-brain barrier.
    Galindo DC; Banks WA; Rhea EM
    Endocrinol Diabetes Metab; 2020 Jul; 3(3):e00149. PubMed ID: 32704569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium.
    Wang Z; Sharda N; Omtri RS; Li L; Kandimalla KK
    Mol Pharmacol; 2023 Nov; 104(5):203-213. PubMed ID: 37541759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconvolution of Plasma Pharmacokinetics from Dynamic Heart Imaging Data Obtained by Single Positron Emission Computed Tomography/Computed Tomography Imaging.
    Wang Z; Wang L; Ebbini M; Curran GL; Min PH; Siegel RA; Lowe VJ; Kandimalla KK
    J Pharmacol Exp Ther; 2023 Jul; 386(1):102-110. PubMed ID: 37221092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of β-amyloid on blood-brain barrier properties and function.
    Petrushanko IY; Mitkevich VA; Makarov AA
    Biophys Rev; 2023 Apr; 15(2):183-197. PubMed ID: 37124923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for an alternative insulin transporter at the blood-brain barrier.
    Banks WA; Noonan C; Rhea EM
    Aging Pathobiol Ther; 2022; 4(4):100-108. PubMed ID: 36644126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment.
    Deng C; Chen H; Meng Z; Meng S
    Front Endocrinol (Lausanne); 2022; 13():955618. PubMed ID: 36213283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin.
    Zhou AL; Sharda N; Sarma VV; Ahlschwede KM; Curran GL; Tang X; Poduslo JF; Kalari KR; Lowe VJ; Kandimalla KK
    J Alzheimers Dis; 2022; 85(3):1031-1044. PubMed ID: 34924382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood-Brain Barrier.
    Zhou AL; Swaminathan SK; Salian VS; Wang L; Curran GL; Min HK; Lowe VJ; Kandimalla KK
    Mol Pharm; 2024 May; 21(5):2176-2186. PubMed ID: 38625027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
    Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semimechanistic Population Pharmacokinetic Modeling to Investigate Amyloid Beta Trafficking and Accumulation at the BBB Endothelium.
    Wang Z; Sharda N; Curran GL; Li L; Lowe VJ; Kandimalla KK
    Mol Pharm; 2021 Nov; 18(11):4148-4161. PubMed ID: 34664956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular imaging of beta-amyloid plaques in the brain].
    Ono M
    Brain Nerve; 2007 Mar; 59(3):233-40. PubMed ID: 17370649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.